SG Americas Securities
ETON icon

SG Americas Securities’s Eton Pharmaceutcials ETON Stock Holding History

SG Americas Securities’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,471
Closed -$109K – 3374
2025
Q4 		$109K Buy
+6,471
New +$114K ﹤0.01% 3213

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

SG Americas Securities's ETON Position: Q1 2026 in Review

SG Americas Securities sold out of Eton Pharmaceutcials (ETON) in Q1 2026, closing a stake of 6,471 shares — an estimated $109K sold.

SG Americas Securities first reported a position in ETON in Q4 2025 and held it in 1 quarter. The position peaked at $109K in Q4 2025. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • SG Americas Securities reported no remaining Eton Pharmaceutcials position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 6,471 Eton Pharmaceutcials shares in Q1 2026, an estimated $109K.
  • SG Americas Securities first reported a position in Eton Pharmaceutcials in Q4 2025 and held it in 1 quarter.
  • SG Americas Securities's Eton Pharmaceutcials position peaked at $109K in Q4 2025.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.